A Lipitor lawsuit was filed by a woman who alleged that taking Lipitor caused her to develop type-2 diabetes.
Lipitor is a drug designed to help control cholesterol levels and decrease the risk of heart disease. However, the Lipitor lawsuit filed by plaintiff Rhonda Harvey—along with thousands of other similar lawsuits — have alleged that the drug can cause diabetes, particularly in woman.
Diabetes is a disease that involves losing the ability to control the amount of sugar (glucose) in the blood. Sugar can build to toxic levels in the blood of diabetics, causing a host of complications including blindness and gangrene.
According to her Lipitor diabetes lawsuit, Harvey started taking Lipitor in May 2002 and continued to take the drug through September 2007. In March 2007, Harvey received a diagnosis of type-2 diabetes.
Her Lipitor lawsuit is joining others in a type of group legal action called a multidistrict litigation, or MDL. MDLs are a coordinated group of similar lawsuits. In many ways MDLs are similar to class action lawsuits. For example, in both class action lawsuits and MDLs, a group of plaintiffs allege that they have suffered similar harms at the hands of the same defendant. The main difference is that MDLs start out as a group of similar lawsuits, while class action lawsuits are started as group lawsuits.
The various cases in the Lipitor MDL, including Harvey’s, have made the accusation that the makers of Lipitor reasonably should have been aware of the potential link between Lipitor and type-2 diabetes. The lawsuits in the MDL allege that studies have suggested a link for years, and post-market surveillance and studies have repeatedly revealed a link. The Lipitor lawsuits in the MDL also assert the drug’s manufacturers deliberately downplayed the risk. For example, when the FDA demanded changes to the labeling of the drug to reflect the risk of diabetes, the makers of the drug added a statement about “elevated glucose levels” and made no reference to diabetes by name.
The Lipitor MDL is In re: Lipitor (Atorvastatin Calcium) Marketing, Sales Practices and Products Liability Litigation (No. II), MDL No. 2502, in U.S. District Court for the District of South Carolina.
In general, Lipitor diabetes lawsuits are filed individually by each plaintiff and are not class actions.
Do YOU have a legal claim? Fill out the form on this page now for a free, immediate, and confidential case evaluation. The attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual lawsuit or class action lawsuit is best for you. Hurry — statutes of limitations may apply.
ATTORNEY ADVERTISING
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2026 Top Class Actions® LLC
Various Trademarks held by their respective owners
This website is not intended for viewing or usage by European Union citizens.
Get Help – It’s Free
Join a Free Lipitor Class Action Lawsuit Investigation
If you’re a woman who was diagnosed with type-2 diabetes while taking Lipitor, or were diagnosed with diabetes within 90 days or less of your last dose of Lipitor, you may be eligible for compensation. See if you qualify by filling out the short form below.
An attorney will contact you if you qualify to discuss the details of your potential case at no charge to you.
Oops! We could not locate your form.
